Skip to content

To determine the effect of diet and consuming a traditional Iranian medicine syrup or honey and vinegar (Sekanjebin) in preventing anxiety and depression in post CABG patients: a randomized clinical trial

To determine the effect of diet and consuming a traditional Iranian medicine syrup or honey and vinegar (Sekanjebin) in preventing anxiety and depression in post CABG patients: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015030921386N1
Enrollment
90
Registered
2015-11-25
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety and depression in post CABG patients. Postprocedural disorder of circulatory system, unspecified

Interventions

Intervention 1: first group: observing diet and consuming 3 glassese per day of a traditional Iranian medicine syrup after CABG for 4 weeks that will be evaluated by Beck questionnaire before the stu
Treatment - Drugs
first group: observing diet and consuming 3 glassese per day of a traditional Iranian medicine syrup after CABG for 4 weeks that will be evaluated by Beck questionnaire before the study and at the en
second group of intervention: consuming 3 glassese per day of honey and vinegar (Sekanjebin) syrup after CABG for 4 weeks that will be evaluated by Beck questionnaire before the study and at the end o
third group (control group): will be evaluated by Beck questionnaire before the study and at the end of 4 weeks.

Sponsors

Shiraz University of Medical science, Vice-Chancellor of Research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: inclusion: CABG operation exclusion:positive past history of anxiety disorder under treatment; positive past history of depression under treatment; current usage of antidepressant and antianxiety drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety and depression. Timepoint: before intervention and 4 weeks following end of intervention. Method of measurement: Beck Depression Score.

Secondary

MeasureTime frame
Amount of anti-anxiety and antidepressant drugs. Timepoint: 4 weeks. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohadeseh

Ostovar

ostovarm@sums.ac.ir+98 71 3635 6781

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026